Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy

NCT03887442 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped low recruitment rate

Conditions

Head and Neck Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cetuximab + Paclitaxel

Sponsor

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Collaborators

[object Object]
[object Object]